학술논문

DOC-MEK: a double-blind randomized phase II trial of docetaxel with or without selumetinib in wild-type BRAF advanced melanoma
Document Type
Article
Source
In Annals of Oncology May 2014 25(5):968-974
Subject
Language
ISSN
0923-7534